Unknown OBSERVATIONAL NCT04060641

Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension (GxRDxHTN)

Sponsor: Geneticure, LLC

Interventions Geneticure for RDN Genetic Panel

Updated 7 times since 2019 Last updated: Feb 1, 2022 Started: Dec 5, 2019 Primary completion: May 1, 2022 Completion: Sep 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hypertension and is currently ongoing. Geneticure, LLC leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Mar 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Mar 2022 — Mar 2024 [monthly]

Recruiting

Status: Unknown Status → Recruiting
Oct 2021 — Mar 2022 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status

▶ Show 2 earlier versions

Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting
Sep 2019 — Jan 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Geneticure, LLC

Data source: Geneticure, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States